Targeted News Service

McDermott Will & Emery Advises Orakl Oncology on a EUR 11 Million Seed Funding Round
December 21, 2024

CHICAGO, Illinois, Dec. 21 -- McDermott Will and Emery, a law firm, issued the following news release:

McDermott Will & Emery advised Orakl Oncology, a pioneering precision oncology company, on a EUR 11 million seed funding round, led by Singular, with support from Bpifrance including the Grand Prix i-Lab, and participation from existing investors.

This new funding will be used to accelerate the company's growth and support the launch of two new commercial prod . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form